**Education Background:** Doctoral degree from Peking University Health Science Center; Postdoctoral research at Cardiff University, UK (May 2013 – May 2014). **Research Focus:** Comprehensive treatment of advanced gastric cancer combining perioperative pharmacotherapy with radical surgery. **Research Achievements:** Principal investigator of a National Natural Science Foundation of China (Young Scientists Fund) and the Beijing Municipal Administration of Hospitals’ “Qingmiao” Young Talent Training Program. Published 10 SCI articles as first author, with a cumulative impact factor of 103. **Clinical Work:** Perioperative pharmacotherapy (chemotherapy, targeted therapy, immunotherapy) for advanced gastric cancer, laparoscopic minimally invasive surgery, and total laparoscopic digestive tract reconstruction, particularly preoperative pharmacotherapy combined with minimally invasive surgery for gastroesophageal junction cancer, gastric function preservation, and high-level anastomosis. Conversion therapy and surgery for advanced gastric cancer with liver metastasis or para-aortic lymph node metastasis. Minimally invasive surgery for colorectal cancer and low rectal cancer, multidisciplinary collaboration for advanced colon cancer, and surgical treatment after conversion therapy. Pharmacotherapy combined with surgery for gastrointestinal stromal tumors and neuroendocrine carcinoma.